N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma
2022 · Molecular Cancer · 98 citations
https://doi.org/10.1186/s12943-022-01549-1
L
Lifeng Ding
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
984
Citations
16
h-index
19
i10-index
Lifeng Ding is an academic researcher from Sir Run Run Shaw Hospital. The author has contributed to research in topics: RNA modifications and cancer & MicroRNA in disease regulation & Circular RNAs in diseases. The author has an h-index of 16, co-authored 46 publications.
ORCID: 0000-0002-1145-9584Papers by this author
workscircPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA
2022 · Journal of Experimental & Clinical Cancer Research · 71 citations
https://doi.org/10.1186/s13046-022-02391-5
Role of noncoding RNA in drug resistance of prostate cancer
2021 · Cell Death and Disease · 64 citations
https://doi.org/10.1038/s41419-021-03854-x
m6Am Methyltransferase PCIF1 Promotes LPP3 Mediated Phosphatidic Acid Metabolism and Renal Cell Carcinoma Progression
2024 · Advanced Science · 9 citations
https://doi.org/10.1002/advs.202404033
Integrated machine learning reveals the role of tryptophan metabolism in clear cell renal cell carcinoma and its association with patient prognosis
2024 · Biology Direct · 9 citations
https://doi.org/10.1186/s13062-024-00576-w
WTAP-dependent N6-methyladenosine methylation of lncRNA TEX41 promotes renal cell carcinoma progression
2024 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-024-76326-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat